Skip to Content

JavaScript has been disabled within your browser, the content or the functionality of this web page can be limited or unavailable.

There is no panel matching the key "Alert---Site-Wide"

Clinical Trials Search Results

Search for

in

Accepting Participants (2)

Showing 1-2 of 2

Sorted By:

A-Z
Z-A

Previous Next

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents = 6 to <18 years of age
This study is looking to evaluate the safety and efficacy of the use of rimegepant in the pediatric population to treat acute migraines in patients ages = 6 to <18 old with a history of migraines.
An Interventional, Efficacy, And Safety, Phase 3 Randomized, Double-Blind, Placebo-Controlled Study With An Open-Label Extension To Investigate Rimegepant In Migraine Prevention In Adolescents 12 To Less Than 18 Years Of Age With Chronic Migraine
The purpose of this study is to learn about the effect of a study medicine called rimegepant in adolescents who have frequent migraine attacks.

Previous Next